Cerus to Release First Quarter 2014 Results on May 1, 2014
CONCORD, Calif. -- April 21, 2014
Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter
results will be released on Thursday, May 1 2014, after the close of the stock
market. The company will host a conference call and webcast at 4:15 PM ET that
afternoon, during which management will discuss the Company’s financial
results and provide a general business overview and outlook.
To access the live webcast, please visit the Investor Relations page of the
Cerus website at http://www.cerus.com/ir. Alternatively, you may access the
live conference call by dialing 866-235-9006 (U.S.) or 631-291-4549
A replay will be available on the company’s website, or by dialing
855-859-2056 (U.S.) or 404-537-3406 (international) and entering conference ID
number 13511524. The replay will be available approximately three hours after
the call through May 14, 2014.
Cerus Corporation is a biomedical products company focused in the field of
blood safety. Cerus currently markets and sells the INTERCEPT Blood System for
both platelets and plasma in Europe, the Commonwealth of Independent States,
the Middle East and selected countries in other regions around the world. In
the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood
System for plasma and platelets. The INTERCEPT red blood cell system is in
clinical development. See http://www.cerus.com for more information.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.
Kevin D. Green, 925-288-6138
Vice President, Finance & CFO
Press spacebar to pause and continue. Press esc to stop.